Skip to main content
SpringerLink
Log in

Movement Disorders

Participating journal: Journal of Neurology

During the last few years, the diagnosis and treatment of movement disorders has significantly improved and with this, exciting new avenues are opening up both scientifically and in clinical practice. This has been driven by a range of new investigative tools including genetics, imaging, biomarker development, all of which has led to new therapeutic approaches that are designed to target the key pathology- whether it be some pathogenic protein driving that disease or some dysfunctional cellular process. All of this has been underpinned by astute clinical observations, as well as the establishment of international consortia working to better define the natural history and heterogeneity of disease.

This article collection aims to gather relevant work on some of the new approaches to better understand, manage and treat movement disorders, so that researchers and clinicians can easily access reviews, original articles, short commentaries and case reports on this subject.

Submissions on this topic are subject to the rigorous peer review the journal conducts for all unsolicited manuscripts. Peer review of manuscripts within this topic is steered by Prof. Roger Barker, one of the Chief Editors of Journal of Neurology.

Participating journal

Submit your manuscript to this collection through the participating journal.

Editors

  • Roger A. Barker, BA, MBBS, MRCP, PhD, University of Cambridge, UK

    Roger A. Barker, BA, MBBS, MRCP, PhD, is the Professor of Clinical Neuroscience at the University of Cambridge and an Honorary Consultant Neurologist at Addenbrooke’s Hospital, Cambridge. His research concentrates on defining the nature and basis for the heterogeneity of Parkinson’s and Huntington’s disease as well as experimental therapeutics including cell and gene therapies. He is the new chair of neurodegeneration at LifeArc, President of the World Parkinson Coalition and a PI at the Cambridge Stem Cell Institute.

  • Simon J. G. Lewis, MBBCh, BSc, MD, University of Sydney, Australia

    Simon J. G. Lewis, MBBCh, BSc, MD, is Professor of Cognitive Neuroscience at the University of Sydney and an Honorary Consultant Neurologist at Royal Prince Alfred Hospital, Sydney. His research program has focused on identifying the neural correlates of troublesome motor and non-motor symptoms in Parkinson’s and Dementia with Lewy Bodies utilising novel neuroimaging and neurophysiological approaches. He is also heavily involved in clinical trials and is the Clinical Lead for the Australian Parkinson’s Mission, which supported by the federal government is committed to establishing a series of disease modifying trials for Parkinson’s.

  • Francesca Morgante, MD, PhD, St George's University of London, UK

    Francesca Morgante, MD, PhD, St George's University of London, London, United Kingdom

Articles

Showing 1-25 of 25 articles

Search

Navigation